Carleen Kluger

Carleen Kluger currently serves as the Group Leader in Clinical Proteomics at Evotec, a position held since September 2019, after progressing through various roles including Research Scientist in Chemical Biology and Bioinformatics. Prior to Evotec, Carleen Kluger completed a PostDoc at LMU - Ludwig-Maximilians-Universität München from January 2017 to August 2019. Carleen began a research career as a PhD Candidate at the Max Planck Institute of Biochemistry from October 2012 to December 2016. Academic credentials include a Master's degree in Physics obtained from Ludwig-Maximilians-Universität München between 2006 and 2011.